The size of the Pharmaceutical Filtration Market Size in North America was worth USD 6.17 billion in 2022. This value is projected to be growing at a CAGR of 8.3% from 2022 to 2027 and a value of USD 9.20 billion by 2027.
The rise of biologics productions and y-o-y growth in the large molecules are majorly driving the North America Pharmaceutical filtration market. The Biopharmaceuticals in the pharmaceutical industry finds filtration application vastly compared to others. Some of the other attributing factors are the rise of cell therapy usage, gene therapy, and recombinant therapies to treat various diseases and disorders like diabetes, malignancy, and rheumatoid arthritis. Moreover, looms of patent cliff and the effectiveness of treatments offered by biologics compel the pharmaceutical companies to develop new biologics. The rise in the adoption of filtration methods to manufacture many biologists result in this industry growth.
North American pharmaceutical filtration market has restraining factors such as harsh regulations of governments for validation in the process of filtration. The primary restraint is obtaining FDA approvals for innovative and new products.
This research report on the North American Pharmaceutical Filtration Market has been segmented and sub-segmented into the following categories:
By the Scale of Operation:
Geographically, the North American market is holding the largest share with a high compound annual growth rate in the global pharmaceutical filtration market due to the growth of pharmaceutical industries because of key players' presence. Additionally, the rise of demand for advanced filtration products in pharmaceutical products and the improvement of healthcare facilities support this growth. Moreover, the increase in R&D activities of sectors in the United States and Canada is likely to fuel future developments. Among all countries, Canada is holding the highest share due to the presence of numerous companies in the manufacturing of pharmaceutical products, falling under multiple categories that include subsidiaries of international companies, generic companies, multinational products of brand-name drugs not qualifying secure patents, among others. The surge in pharmaceutical sales due to the growth of industries is creating opportunities for the local pharmaceutical filtration market.
Some of the Prominent Companies dominating the North America Pharmaceutical Filtration Market Profiled in the Report are Merck KGaA, Pall Corporation, GE Healthcare, 3M Company, Parker Hannifin Corporation, Sartorius Stedim Biotech S.A., Eaton Corporation PLC, Graver Technologies, LLC, Amazon Filters Ltd., and Meissner Filtration Products, Inc.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org